论文部分内容阅读
The recombinant Saccharomyces cerevisiae strain stably expressing recombinant human glucagon-like peptide-1(rhGLP-1) analogue, as a potential oral drug delivery system for diabetes type Ⅱ treatment, was successfully constructed by the homologous recombina